HB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open | 2025 | 13 | 3 | |||
Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children | Frontiers in immunology | 2025 | 4 | 4 | |||
Acne-Related Quality of Life and Mental Health Among Adolescents : A Cross-Sectional Analysis | Clinical and experimental dermatology | 2024 | 20 | 12 | |||
Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases : A Cross-Sectional Online Survey | COVID | 2024 | 38 | 29 | |||
Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health | 2023 | 125 | 59 | |||
Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health | 2023 | 74 | 37 | |||
Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health | 2023 | 100 | 41 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | 2023 | 102 | 74 | |||
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study | Infection | 2023 | 60 | 25 | |||
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | 2023 | 113 | 30 | |||
Development of hybrid immunity during a period of high incidence of Omicron infections | International journal of epidemiology | 2023 | 53 | 51 | |||
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open | 2022 | 182 | 67 | |||
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 132 | 79 | |||
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | 2022 | 88 | 24 | |||
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents | Nature communications | 2022 | 176 | 44 | |||
COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 72 | 50 | |||
Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland – A cross-sectional population-based study | Preventive medicine | 2022 | 178 | 147 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | 2021 | 206 | 97 | |||
Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | 2021 | 345 | 120 | |||
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications | 2021 | 218 | 100 | |||
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study | Viruses | 2021 | 205 | 73 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | 2021 | 237 | 145 | |||
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study | Scandinavian journal of public health | 2021 | 263 | 91 | |||
Perceptions of vaccination certificates among the general population in Geneva, Switzerland | Swiss medical weekly | 2021 | 51 | 26 | |||
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet | 2020 | 698 | 14 | |||
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland | International Journal of Public Health | 2020 | 235 | 81 | |||
A twelve-year study of the prevalence, risk factors and characteristics of interval colorectal cancers after negative colonoscopy | Clinics and research in hepatology and gastroenterology | 2020 | 23 | 15 | |||
La pharmacie clinique en milieu hospitalier : une enquête de satisfaction auprès des prescripteurs | Annales pharmaceutiques françaises | 2017 | 49 | 0 | |||
Exposition domestique au radon et risque de cancer du poumon: Les résultats d’une étude épidémiologique menée en France | Revue des maladies respiratoires | 2005 | 39 | 0 | |||
Indoor radon and lung cancer in France | Epidemiology | 2004 | 55 | 0 | |||
Seasonal correction factors for estimating radon exposure in dwellings in France | Radiation protection dosimetry | 2003 | 48 | 0 |